Sandhill Capital Partners LLC Charles River Laboratories International, Inc. Transaction History

Sandhill Capital Partners LLC

  • $1.23 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$203.52 - $273.43 $164,444 - $220,931
808 New
808 $218,000
Q2 2022

Aug 10, 2022
SELL
$204.13 - $302.4 $165,141 - $244,641
-809 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$372.64 - $458.3 $745 - $916
-2 Reduced 0.25%
809 $334,000
Q2 2021

Aug 11, 2021
BUY
$294.17 - $371.65 $238,571 - $301,408
811 New
811 $300,000

Others Institutions Holding CRL

# of Institutions
710
Shares Held
53.9M
Call Options Held
122K
Put Options Held
239K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.41B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Sandhill Capital Partners LLC Portfolio

Follow Sandhill Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandhill Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sandhill Capital Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email